Evaluating New Formulation of Therapeutic HSV-2 Vaccine

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This study evaluates the reduction in viral shedding after vaccination with a new formulation of GEN-003 in subjects with genital HSV-2 infection. Two-thirds of the participants will receive GEN-003, one-third will receive placebo.
Epistemonikos ID: 0293854584997517264738ef00e38ddebc79bb67
First added on: May 12, 2024